4
42
K. Fugami et al. / Journal of Organometallic Chemistry 611 (2000) 433–444
3.2.9. exo-cis-2-(p-Fluorophenyl)-3-(trimethylstannyl)-
1H), 0.11 (s, 9H), 0.78–0.94 (m, 3H), 1.16–1.46 (m,
bicyclo[2.2.1]heptane (6f)
6H), 1.55–1.66 (m, 2H), 1.81–1.91 (m, 2H), 1.98–2.05
(m, 2H), 2.11–2.19 (m, 1H), 2.23 (s, 3H), 2.31–2.39 (m,
1H), 2.51 (m, 1H), 2.98 (br.d, J=9.4 Hz, 1H), 7.06–
1
H-NMR (200 MHz, CDCl ): l −0.30 (s, 9H),
3
1
2
2
.31–1.39 (m, 3H), 1.62–1.97 (m, 4H), 2.32–2.53 (m,
H), 3.06 (d, J=10.2 Hz, 1H), 6.94 (tt, J=8.8 Hz,
H), 7.11 (ddt, J=4.0 Hz, 2H). C-NMR (125.7 MHz,
13
7.15 (m, 3H), 7.30–7.34 (m, 1H). C-NMR (125.7
1
3
MHz, CDCl ): l −8.2, 20.5, 30.8, 30.9, 31.2, 32.4,
3
CDCl3): l −9.2, 31.0, 32.6, 37.5, 41.0, 44.2, 42.6, 50.2,
37.1, 37.2, 37.4, 38.2, 40.1, 40.9, 43.4, 45.9, 50.4, 55.7,
1
19
114.9, 115.3, 128.8, 128.9, 144.5, 163.6.
Sn-NMR
125.5, 125.7, 126.2, 129.6, 137.2, 142.3. MS (m/z): 429
+
+
(
186.4 MHz, CDCl ): l −13.7. MS (m/z): 339 (M −
(M −Me, 36%), 278 (22%), 161 (48%), 131 (33%), 105
3
Me, 97%), 337 (70%), 245 (69%), 165 (74%), 133 (33%),
(100%), 91 (32%), 79 (34%).
109 (100%), 67 (35%).
3.2.10. exo-cis-2-Phenyl-3-(trimethylstannyl)bicyclo-
3.2.14. exo-cis-2-(p-methoxyphenyl)-3-(trimethyl-
[
2.2.1]heptane (6g)
stannyl)bicyclo[2.2.1]heptane (6i)
1
1
H-NMR (200 MHz, CDCl ): l −0.31 (s, 9H),
H-NMR (200 MHz, CDCl ): l −0.31 (s, 9H),
3
3
1
2
.33–1.40 (m, 3H), 1.63–1.99 (m, 4H), 2.33–2.59 (m,
1.30–1.37 (m, 3H), 1.60–1.96 (m, 4H), 2.30–2.55 (m,
H), 3.09 (d, J=10.4 Hz, 1H), 7.13–7.30 (m, 5H).
2H), 3.02 (d, J=10.0 Hz, 1H), 3.78 (s, 3H), 6.79 (dt,
1
3
13
C-NMR (125.7 MHz, CDCl ): l −9.3, 31.0, 32.7,
J=9.0 Hz, 2H), 7.06 (dt, J=8.6 Hz, 2H). C-NMR
3
3
1
1
7.6, 41.1, 41.9, 42.7, 50.9, 125.7, 127.5, 127.6, 128.5,
(125.7 MHz, CDCl ): l −9.2, 31.0, 32.7, 37.5, 40.9,
42.2, 43.0, 50.1, 55.2, 113.8, 128.4, 141.1, 157.7. Sn-
3
1
19
119
28.6, 148.6.
Sn-NMR (186.4 MHz, CDCl ) l −
3
+
3.9. MS (m/z): 321 (M −Me, 77%), 227 (43%), 225
NMR (186.4 MHz, CDCl ): l −15.0. MS (m/z): 351
3
+
(
(
31%), 165 (54%), 135 (21%), 115 (24%), 91 (100%), 67
44%). Anal. Found: C, 57.57; H, 7.37. Calc. for
(M –Me, 100%), 257 (99%), 253 (42%), 201 (26%), 165
(33%), 121 (68%). Anal. Found: C, 55.68; H, 7.18. Calc.
C H Sn: C, 57.36; H, 7.22%.
for C H Sn: C, 55.93; H, 7.18%.
17 26
1
6
24
3.2.11. exo-cis-2-(exo-cis-3-Phenylbicyclo[2.2.1]-
hept-2-yl)-3-trimethylstannylbicyclo[2.2.1]heptane (7g)
3.2.15. exo-cis-2-{exo-cis-3-(p-methoxyphenyl)-
bicyclo[2.2.1]hept-2-yl}-3-trimethylstannylbicyclo[2.2.1]-
1
H-NMR (200 MHz, CDCl ): l 0.10 (s, 9H), 0.34–
3
0
1
2
.47 (m, 1H), 0.78–0.97 (m, 2H), 1.05–1.75 (m, 11H),
.81–1.92 (m, 1H), 2.00–2.19 (m, 2H), 2.41 (m, 2H),
.91 (d, J=9.2 Hz, 1H), 7.09–7.29 (m, 5H). C-NMR
heptane (7i)
1
H-NMR (200 MHz, CDCl ): l 0.10 (s, 9H), 0.42–
3
13
0.58 (m, 1H), 0.82–1.00 (m, 2H), 1.06–1.70 (m, 11H),
1.82–1.89 (m, 1H), 2.03–2.10 (m, 2H), 2.16–2.38 (m,
2H), 2.87 (d, J=9.0 Hz, 1H), 3.79 (s, 3H), 6.80 (dt,
(
125.7 MHz, CDCl ): l −7.8, 30.4, 30.8, 31.2, 31.9,
3
3
1
6.6, 37.0, 38.1, 38.5, 40.9, 42.4, 43.8, 53.3, 46.4, 58.1,
+
13
11.9, 125.5, 127.8, 129.2, 144.1. MS (m/z): 415 (M −
J=8.8 Hz, 2H), 7.12 (dt, J=8.8 Hz, 2H). C-NMR
Me, 83%), 265 (36%), 161 (45%), 143 (22%), 117 (40%),
1 (100%), 79 (31%), 67 (48%). Anal. Found: C, 64.72;
H, 8.18. Calc. for C H Sn: C, 64.36%, H: 7.99%.
(125.7 MHz, CDCl ): l −7.8, 30.3, 30.8, 31.3, 31.9,
3
9
36.5, 37.0, 38.2, 38.5, 40.9, 42.8, 43.9, 46.4, 52.6, 55.1,
+
58.2, 113.2, 130.0, 136.3, 157.6. MS (m/z): 460 (M ,
17
26
1
%), 445 (69%), 295 (41%), 161 (26%), 121 (100%), 91
3
.2.12. exo-cis-2-(o-Tolyl)-3-(trimethylstannyl)bicyclo-
(22%), 67 (24%). Anal. Found: C, 62.11; H, 7.98. Calc.
for C H Sn: C, 62.77; H, 7.90%.
[
2.2.1]heptane (6h)
24
36
1
H-NMR (200 MHz, CDCl ): l −0.34 (s, 9H),
3
1
2
.35–1.40 (m, 3H), 1.54–2.08 (m, 4H), 2.26 (s, 3H),
.34–2.55 (m, 2H), 3.14 (d, J=10.0 Hz, 1H), 6.99–7.26
3.2.16. exo-cis-2-Phenyl-3-(triphenylstannyl)-
1
3
(m, 4H). C-NMR (125.7 MHz, CDCl ): l −9.2, 20.3,
bicyclo[2.2.1]heptane (6j)
3
1
3
1
1.7, 32.4, 37.8, 41.1, 41.4, 42.0, 46.9, 125.3, 125.7,
26.3, 130.5, 135.8, 146.5.
H-NMR (200 MHz, CDCl ): l 1.35–1.88 (m, 6H),
3
119
Sn-NMR (186.4 MHz,
2.43–2.53 (m, 1H), 2.72 (dd, J=10.1, 2.5 Hz, 1H),
2.75–2.80 (m, 1H), 3.19 (d, J=10.1 Hz, 1H), 6.90–7.02
+
CDCl ): l −12.1. MS (m/z): 335 (M −Me, 87%),
2
1
3
13
41 (57%), 239 (43%), 165 (55%), 128 (23%), 115 (22%),
05 (100%), 91 (29%), 77 (21%), 67 (35%). Anal.
(m, 5H), 7.18–7.34 (m, 15H). C-NMR (50 MHz,
CDCl ): l 31.0, 32.7, 37.7, 41.3, 43.0, 44.8, 51.5,
3
Found: C, 57.10; H, 7.30. Calc. for C H Sn: C, 58.49;
H, 7.51%.
126.1, 127.7, 128.09, 128.13, 128.3, 128.37, 128.47,
17
26
119
128.56, 128.62, 136.9, 137.6, 140.6, 148.4. Sn-NMR
+
(
186.4 MHz, CDCl ): l 179.4. MS (m/z): 522 (M ,
3
+
3
[
(
.2.13. exo-cis-2-{exo-cis-3-(o-tolyl)bicyclo-
2.2.1]hept-2-yl}-3-trimethylstannylbicyclo[2.2.1]heptane
7h)
0.3%), 519 (0.2%), 445 (M −Ph, 0.4%), 351 (100%),
197 (24%), 120 (21%), 91 (34%), 67 (18%). Anal.
Found: C, 71.36; H, 5.80. Calc. for C H Sn: C, 71.43;
31
30
1
H-NMR (200 MHz, CDCl ): l −0.20–0.00 (m,
H, 5.80%.
3